During the past decade, Company for Medical Study & Service Selters conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Company for Medical Study & Service Selters" are "Psoriasis" (2 trials). Many other conditions were trialed in "Company for Medical Study & Service Selters" in a lesser frequency.

Most popular intervention types in "Company for Medical Study & Service Selters" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Guselkumab" (2 trials), "Etanercept" (1 trials), "Placebo Injection" (1 trials) and "Placebo for guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Company for Medical Study & Service Selters" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Company for Medical Study & Service Selters". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Company for Medical Study & Service Selters, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Company for Medical Study & Service Selters, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".